U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
GW-5074
P0LE4QW0S6
Investigational
General
Activity
Names
4
Identifiers
3
Mixture Components
2
Related Substances
1
GW-5074
P0LE4QW0S6
Investigational
General
Approval Year
Unknown
139,594
Activity
Targets
Targets
Primary Target
Pharmacology
Condition
Potency
Serine/threonine-protein kinase RAF
10
Inhibitor
8,297
4.4 nM [IC50]
Names
4
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
GW-5074
Code
English
3-((3,5-DIBROMO-4-HYDROXYPHENYL)METHYLENE)-1,3-DIHYDRO-5-IODO-2H-INDOL-2-ONE
Systematic Name
English
2H-INDOL-2-ONE, 3-((3,5-DIBROMO-4-HYDROXYPHENYL)METHYLENE)-1,3-DIHYDRO-5-IODO-
Systematic Name
English
GW5074
Code
English
Showing 1 to 4 of 4 entries
Previous
1
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
EPA CompTox
DTXSID10421368
PRIMARY
FDA UNII
P0LE4QW0S6
PRIMARY
CAS
220904-83-6
PRIMARY
Showing 1 to 3 of 3 entries
Previous
1
Next
Mixture Components
2
All of the following components
must
be present:
S69D6672SX
GW-5074 (E)-
B7W8RS1GG2
GW-5074, (Z)-
Related Substances
1
ACTIVE MOIETY
P0LE4QW0S6
GW-5074
Definition References
(1)
